Search Within

Nikoletta Lendvai

Formats
  1. Meeting Abstract (71)
  2. Journal Article (33)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (106)
  2. Department of Medicine (106)
  3. Hematologic Malignancies, Division of (106)
  4. Myeloma (106)
  5. Hematologic Malignancies Research (77)
  6. Survivorship Research (74)

More Groups

People
  1. Alexander Lesokhin (71)
  2. Hani Hassoun (70)
  3. Heather Landau (68)
  4. Sergio Giralt (67)
  5. David Chung (61)
  6. Carl Landgren (53)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (7)
  4. 2019 (7)
  5. 2018 (14)
  6. 2017 (13)

More Years

Publications
  1. Blood (46)
  2. Biology of Blood and Marrow Transplantation (14)
  3. Leukemia and Lymphoma (9)
  4. Bone Marrow Transplantation (6)
  5. Journal of Clinical Oncology (6)
  6. Clinical Lymphoma, Myeloma and Leukemia (5)

More Publications

Publishers
  1. American Society of Hematology (47)
  2. Elsevier Inc. (21)
  3. Nature Publishing Group (10)
  4. Taylor & Francis Group (9)
  5. American Society of Clinical Oncology (6)
  6. Ferrata Storti Foundation (5)

More Publishers

Results (106)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Proteomic profiling in plasma cell disorders: A feasibility study
    Journal Article

    Mailankody, S.; Devlin, S. M.; Korde, N.; Lendvai, N.; Lesokhin, A.; Landau, H.; Hassoun, H.; Ballagi, A.; Ekman, D.; Chung, D. J.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: Efficacy and analysis of risk factors associated with poor stem cell collection efficiency*
    Journal Article

    Ogunniyi, A.; Rodriguez, M.; Devlin, S.; Adel, N.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Koehne, G.; Mailankody, S.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • A phase lb dose escalation trial of isatuximab (SAR650984, anti-CD38 mAb) plus lenalidomide and dexamethasone (Len/Dex) in relapsed/refractory multiple myeloma (RRMM): Interim results from two new dose cohorts
    Meeting Abstract

    Vij, R.; Lendvai, N.; Martin, T. G.; Baz, R. C.; Campana, F.; Mazuir, F.; Charpentier, E.; Benson, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Richter, J. R.; Martin, T. G.; Vij, R.; Cole, C.; Atanackovic, D.; Zonder, J. A.; Kaufman, J. L.; Mikhael, J.; Bensinger, W.; Dimopoulos, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Whole exome sequencing from nine independent sites of extraosseous disease in a single patient with relapsed multiple myeloma show that extramedullary disease arise through a combination of branched and parallel evolution
    Meeting Abstract

    Landau, H.; Fan, J.; Giralt, S. A.; Peled, J. U.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Longitudinal (18)f-FDG-PET-CT analysis in newly diagnosed multiple myeloma (NDMM) patients following carfilzomib, lenalidomide, dexamethasone induction and lenalidomide maintenance (CRd-R)
    Meeting Abstract

    Korde, N. S.; Kazandjian, D.; Roschewski, M.; Mailankody, S.; Hultcrantz, M.; Yuan, C. M.; Stetler-Stevenson, M.; Choyke, P.; Hassoun, H.; Lesokhin, A. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparison of standard assays (serum immunofixation and protein electrophoresis) with Hevylite assay in patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Ruiz, R.; Kazunori, M.; Azzi, K.; Devlin, S.; Cooper, B.; Lendvai, N.; Landau, H.; Lesokhin, A. M.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy
    Meeting Abstract

    Hassoun, H.; Roshal, M.; Sabari, J.; Cooper, B.; Nguyen, J.; Ruiz, R.; Gao, Q.; Landau, H.; Lendvai, N.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation
    Journal Article

    Landau, H.; Wood, K.; Chung, D. J.; Koehne, G.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Zheng, J. T.; Devlin, S. M.; more...
    Leukemia and Lymphoma (2016)

    Fulltext@MSK | Save